TRAVERE THERAPEUTICS INC

CUSIP: 89422GAA5 Class: Convertible Debt

SILVERBACK ASSET MANAGEMENT LLC's Holding History (CIK: 0001278960)

Note: Option positions (PUT/CALL) are excluded.

Q3 2024
Shares 13,225,000 Value ($000) $11,431 Avg Close — Range —
Q2 2024
Shares 15,000,000 Value ($000) $9,758 Avg Close — Range —
Q1 2024
Shares 16,500,000 Value ($000) $10,499 Avg Close — Range —
Q4 2023
Shares 15,000,000 Value ($000) $9,950 Avg Close — Range —
Q3 2023
Shares 12,500,000 Value ($000) $8,093 Avg Close — Range —